• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

Accountability- Jorge Reindhardt needs to step down

anonymous

Guest
Accountability is the catch phrase at Novartis being parroted. Maybe good old Jorge should hold himself accountable and step down.

From this day in 2010 to now

Annualized return:
NVS: 8.5%
SPY: 13:0%
XBI: 10.82%

Total Returns:
NVS: 188%
SPY: 389%
XBI: 279%

Hire/fire culture, bean counting, failed launches, and poor investments. How does someone pull the strings for this long with such mediocre results.
 

<



Every single board member and country leads/regional CEOs have failed with our stock price being stagnant over the last 5 years. If you or I didn't show any performance change over 5 years am pretty sure we wouldnt have our jobs.